Industries > Pharma > Global Human Microbiome Therapeutics Market Forecast 2020-2030

Global Human Microbiome Therapeutics Market Forecast 2020-2030

Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders, Dermatological Conditions, Other Disorders

PUBLISHED: 29 November 2019
PAGES: 345
PRODUCT CODE: PHA0622
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0622 Categories: , Tags: ,

The global human microbiome therapeutics market is estimated to grow at a CAGR of 80.2% in the first half of the forecast period. The global human microbiome therapeutics market is estimated to reach $1.6bn in 2025.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 345-page report you will receive 150 tables and 78 figures– all unavailable elsewhere.

The 345-page report provides clear detailed insight into the global human microbiome therapeutics market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Human Microbiome Therapeutics Market forecast from 2020-2030

• Global Human Microbiome Therapeutics Market revenue forecast 2020-2030 by Sector:
• Gastrointestinal Disorders
• Infectious Diseases
• Metabolic Diseases
• Dermatological Conditions
• Other Disorders

• Global Human Microbiome Therapeutics Market revenue forecast 2020-2030 by Region:
• U.S.
• EU5: Germany, France, U.K., Italy, Spain
• APAC: Japan, China, India, Australia, Korea
• Rest of the World

Global Human Microbiome Therapeutics Market Forecast 2020-2030

The human microbiome market revenue forecast 2019-2029 for the US, EU5 and APAC markets are further broken down by sector.

• This report discusses the top 20 companies in the human microbiome therapeutics market:
• 4D Pharma
• AOBiome Therapeutics
• C3J Therapeutics
• Caelus Health
• Enterome Bioscience
• Ferring Pharmaceuticals
• Finch Therapeutics/Crestovo
• IGEN BIOTECH GROUP
• Immuron
• Intrexon Corporation
• MaaT Pharma
• MatriSys Biosystem
• Microbiome Therapeutics LLC
• Osel
• Ritter Pharmaceuticals
• Second Genome
• Seres Therapeutics
• Synlogic
• Synthetic Biologics
• Vedanta Biosciences

This report discusses collaborations and acquisition, recent developments, drugs developments and key pipeline products

• This report lists and discusses the main pipeline products in these main sectors: gastrointestinal disorders submarket, metabolic disorders submarket, infectious diseases submarket, dermatological disorders submarket and other disorders submarket.

• Qualitative analysis of the human microbiome therapeutics market in the form of a SWOT Analysis.

• Key Questions Answered by this Report:
• How is the market for human microbiome therapeutics evolving?
• What is driving and restraining the human microbiome therapeutics market dynamics?
• What are the market shares of the submarkets for gastrointestinal disorders, infectious diseases, metabolic diseases, dermatological conditions, and other disorders from the overall human microbiome therapeutics market?
• How will each of the submarket segments within the human microbiome therapeutics market grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each of the submarkets within the human microbiome therapeutics market develop from 2020 to 2030?
• Which submarkets will be the main driver of growth in the overall market from 2020 to 2030?
• How will the regional market shares in the human microbiome therapeutics market change by 2030 and which geographical region will lead the market in 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the global human microbiome therapeutics market. You find data, trends and predictions.

Buy our report today Global Human Microbiome Therapeutics Market: Gastrointestinal Disorders, Infectious Diseases, Metabolic Disorders, Dermatological Conditions, Other Disorders.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Human Microbiome Therapeutics Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Human Microbiome Therapeutics Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Categories